Literature DB >> 27408191

Diabetes Mellitus in India: The Modern Scourge.

S R Mehta1, A S Kashyap2, S Das3.   

Abstract

India has a high prevalence of diabetes mellitus and the numbers are increasing at an alarming rate. In India alone, diabetes is expected to increase from 40.6 million in 2006 to 79.4 million by 2030. Studies have shown that the prevalence of diabetes in urban Indian adults is about 12.1%, the onset of which is about a decade earlier than their western counterparts and the prevalence of Type 2 diabetes is 4-6 times higher in urban than in rural areas. The risk factors peculiar for developing diabetes among Indians include high familial aggregation, central obesity, insulin resistance and life style changes due to urbanization. Screening for gestational diabetes and impaired glucose tolerance among pregnant women provides a scope for primary prevention of the disease in mothers as well as in their children. The problems of obesity and impaired glucose tolerance (IGT) (important predisposing factors) are not confined to adults alone but children are also increasingly getting affected. Most long standing macro and micro vascular complications are also more common among Indian diabetics as compared to other races and ethnic groups. A strong familial clustering of diabetic nephropathy among Indian Type 2 diabetics has also been noted. Clustering of cardiovascular risk factor like Syndrome X is common among urban Indians. The rising incidence of diabetes and its complications are going to pose a grave health care burden on our country. Timely effective interventions/measures and screening tests for complications at the time of diagnosis becomes imperative not only for early detection, but also to prevent progression to end stage disease. Screening for gestational diabetes among pregnant women would also go a long way in primary prevention of the disease. Life style changes/interventions and drugs like rosiglitazone are the current strategies that can prevent and/or delay the onset of diabetes. Simple interventional strategies like "Eat less, Eat on time and Walk more" can go a long way in preventing these chronic disorders among present as well as in the future generations.

Entities:  

Keywords:  Central obesity; Familial aggregation; Gestational diabetes; Insulin resistance; Type 2 diabetes; Waist hip ratio

Year:  2011        PMID: 27408191      PMCID: PMC4921440          DOI: 10.1016/S0377-1237(09)80056-7

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  33 in total

Review 1.  End-stage renal disease in the Asian-Pacific region.

Authors:  Grace Lee
Journal:  Semin Nephrol       Date:  2003-01       Impact factor: 5.299

Review 2.  Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.

Authors:  A Fagot-Campagna; D J Pettitt; M M Engelgau; N R Burrows; L S Geiss; R Valdez; G L Beckles; J Saaddine; E W Gregg; D F Williamson; K M Narayan
Journal:  J Pediatr       Date:  2000-05       Impact factor: 4.406

3.  High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.

Authors:  A Ramachandran; C Snehalatha; A Kapur; V Vijay; V Mohan; A K Das; P V Rao; C S Yajnik; K M Prasanna Kumar; J D Nair
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

4.  Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study.

Authors:  G Premalatha; S Shanthirani; R Deepa; J Markovitz; V Mohan
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

5.  Clinical profile of diabetic foot infections in south India--a retrospective study.

Authors:  V Vijay; D V Narasimham; R Seena; C Snehalatha; A Ramachandran
Journal:  Diabet Med       Date:  2000-03       Impact factor: 4.359

6.  Incidence of diabetes and pre-diabetes in a selected urban south Indian population (CUPS-19).

Authors:  V Mohan; M Deepa; R M Anjana; H Lanthorn; R Deepa
Journal:  J Assoc Physicians India       Date:  2008-03

7.  Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935.

Authors:  A Must; P F Jacques; G E Dallal; C J Bajema; W H Dietz
Journal:  N Engl J Med       Date:  1992-11-05       Impact factor: 91.245

8.  Clustering of cardiovascular risk factors in urban Asian Indians.

Authors:  A Ramachandran; C Snehalatha; E Latha; K Satyavani; V Vijay
Journal:  Diabetes Care       Date:  1998-06       Impact factor: 19.112

9.  Familial aggregation of type 2 (non-insulin-dependent) diabetes mellitus in south India; absence of excess maternal transmission.

Authors:  M Viswanathan; M I McCarthy; C Snehalatha; G A Hitman; A Ramachandran
Journal:  Diabet Med       Date:  1996-03       Impact factor: 4.359

10.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.

Authors:  P M McKeigue; B Shah; M G Marmot
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

View more
  5 in total

1.  A Case-Control Study to Evaluate Candidal Parameters in the Oral Cavity of Patients with Type 2 Diabetes Mellitus.

Authors:  Lakshmanan Vijayalakshmi; Joseph Babhu Susai Raj; Jayavel Kavitha; Selvaraj Krishnaraj; Balagangadharan Manovijay; Dhanasekaran Manikandan
Journal:  J Pharm Bioallied Sci       Date:  2020-08-28

2.  Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.

Authors:  Mala Dharmalingam; S R Aravind; Hemant Thacker; S Paramesh; Brij Mohan; Manoj Chawla; Arthur Asirvatham; Ramesh Goyal; Jayashri Shembalkar; R Balamurugan; Pradnya Kadam; Hansraj Alva; Rahul Kodgule; Monika Tandon; Sivakumar Vaidyanathan; Amol Pendse; Rajesh Gaikwad; Sagar Katare; Sachin Suryawanshi; Hanmant Barkate
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 3.  COVID-19 and metabolic disease: mechanisms and clinical management.

Authors:  Charlotte Steenblock; Peter E H Schwarz; Barbara Ludwig; Andreas Linkermann; Paul Zimmet; Konstantin Kulebyakin; Vsevolod A Tkachuk; Alexander G Markov; Hendrik Lehnert; Martin Hrabě de Angelis; Hannes Rietzsch; Roman N Rodionov; Kamlesh Khunti; David Hopkins; Andreas L Birkenfeld; Bernhard Boehm; Richard I G Holt; Jay S Skyler; J Hans DeVries; Eric Renard; Robert H Eckel; K George M M Alberti; Bruno Geloneze; Juliana C Chan; Jean Claude Mbanya; Henry C Onyegbutulem; Ambady Ramachandran; Abdul Basit; Mohamed Hassanein; Gavin Bewick; Giatgen A Spinas; Felix Beuschlein; Rüdiger Landgraf; Francesco Rubino; Geltrude Mingrone; Stefan R Bornstein
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-04       Impact factor: 32.069

Review 4.  Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their management.

Authors:  Abhiram Kumar; Kalyani Sakhare; Dwaipayan Bhattacharya; Raktim Chattopadhyay; Purvish Parikh; Kumar P Narayan; Anubhab Mukherjee
Journal:  Front Nutr       Date:  2022-09-21

5.  Frequency of Food Consumption and Self-reported Diabetes among Adult Men and Women in India: A Large Scale Nationally Representative Cross-sectional Study.

Authors:  Sutapa Agrawal
Journal:  J Diabetes Metab       Date:  2015-01-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.